Warning: Undefined array key "label" in /home/equitox/www_new/wp-content/themes/Divi/includes/builder/class-et-builder-element.php on line 9043
Reach regulation and compliance of chemical substance

REACh

  1. AccueilHome
  2.  » REACh

Whether you are a manufacturer or user of chemical substances, Equitox guides you through your REACh regulatory compliance process. Based on the assessment of your obligations, we define the best strategy for your products.

I wish to be in compliance with REACh…

…and I need assistance in the preparation of the technical registration dossier

Equitox

  • Searches for and analyses existing data, and submits Inquiries to ECHA,
  • Determines the registration strategy,
  • Makes exemption requests for product and process-oriented research and development (PPORD),
  • Sets out a data acquisition strategy,
  • Generates missing data,
  • Creates the IUCLID dossier and the Chemical Safety Report (CSR).

…and I would like someone to deal with the administrative part of the registration process for me

Equitox

  • Represents you within SIEFs and consortia,
  • Ensures compliance with data sharing rules and the cost of the letter of access.
  • Manages your REACh-IT account.

…and I would like to update dossiers already registered

Equitox

  • Identifies compliance deviations
  • Assists with substance identification issues,
  • Verifies the strictly controlled conditions (SCC) of intermediates,
  • Updates your dossiers with more relevant data to make sure ECHA does not prioritise your substances.

What happens to my dossier once it has been registered?

What should I do if my dossier is evaluated?

Equitox

  • Explains ECHA’s requests to you,
  • Supports you during consultation stages to bring forward admissible arguments likely to challenge the Authorities’ requirements,
  • Helps ensure the compliance of your dossier, based on its in-depth knowledge of guidance documents and its technical expertise.

What should I do if my substance is evaluated?

Equitox

  • Puts in place an alert on priority substances in your company or on your strategic raw materials, which will be evaluated in the coming years,
  • Informs you of issues targeted by the authorities (e.g. PBT, Endocrine Disruptor, etc.) ,
  • Helps you answer the questions asked. To do this, Equitox develops all its arguments and expertise to minimise resultant costs.

What should I do in the event of a restriction (project)?

Equitox

  • Analyses the impact of this restriction on your markets or raw materials,
  • Explores a range of possible options: production shutdown, development of a substitute product, shifts in the production chain, etc.

What should I do if my substance falls under the authorisation process?

Equitox

  • Identifies in advance potential future substances of very high concern (SVHC),
  • Monitors changes to the candidate list and explains the resulting obligations,
  • Informs you of ECHA prioritisation, substances included in annexe XIV and the consequences for your markets,
  • Contributes to the preparation of your authorisation dossiers.

But also…

I would like assistance in preparing my extended SDSs

Equitox

  • Audits your SDSs,
  • Drafts annexes to SDSs.

I would like to know whether my use complies with my supplier’s eSDS

Equitox

  • Analyses your conditions of use and compares them with those indicated in the exposure scenarios featured in your supplier’s SDS,
  • Facilitates exchanges with your suppliers if deviations are identified,
  • Outlines possible alternatives in case of non-compliance with the eSDS,
  • Draws up the chemical safety report (DU-CSR) taking into account your conditions of use.

I would like assistance in my dealings with national authorities or ECHA

Equitox

  • is involved in interactions with the authorities (written communications and meetings),
  • Queries help desks in a totally confidential manner,
  • Submits notifications to ECHA (authorised use for substance included in Annexe XIV, Candidate list substance in article, use not supported by supplier, different classification).

I would like to be informed of regulatory developments and anticipate future changes

Equitox

  • Regularly monitors developments specific to your situation, products and markets,
  • Anticipates future regulatory developments (Polymers, PMT),
  • Analyses major alerts which may concern your products (classification, restriction, SVHC),
  • Analyses regulatory positioning for your R&D projects.

I would like to conduct a Due Diligence review

Equitox

  • Audits the product portfolio prior to an acquisition or merger, with a view to clearly mapping out the regulatory status of substances,
  • Anticipates possible restrictions or prohibitions which could affect products in the near future.
Equitox
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.